Stocks Laboratory Corporation of America Holdings

  • What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.

  • What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.

  • The Dow clawed back in late trading Wednesday. Technology and industrials gained while health-care and telecom shares continued to drag.

  • Stocks wobbled in mid-afternoon trading Wednesday. Technology and industrials gained while health-care and telecom stocks continued to drag.

  • In today's trading session, a total of 81 stocks in the S&P 500 reached new 52-week highs. Here is a look at those companies.

  • Stocks pushed higher Wednesday, led by techs and banks as optimism about the economic recovery gained strength and worries about the Goldman Sach charges subsided.

  • U.S. stock index futures struggled to find direction ahead of the open Wednesday as investors braced for the next batch of corporate earnings.

  • What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.

  • Stocks rallied off a lower open Thursday as news of a Greek bailout and a sharp drop in jobless claims helped calm jittery investors — and put them in the mood to take some risks. Energy and industrials were the day's best performers; Financials were the worst.

  • Stocks opened lower Thursday as investors shrugged off an encouraging jobless report and news of a bailout for Greece. Financials took a hit, with JPMorgan leading the Dow's decline, as investors worry that debt problems in Europe could spread

  • Stock futures, already in positive territory on an apparent deal to rescue Greece, added to gains on good news from the labor market.

  • earnings_central_badge.jpg

    What follows is a roundup of corporate earnings reports for Thursday, Feb. 11

  • Retail sales, at down 0.3 percent, was below expectations of a gain of 0.5 percent, though November was revised upward, while first time unemployment claims rose slightly more than expected for the week.

  • Specialist business continues to consolidate: LaBranche trades up 30 percent after the close, in a deal that makes Barclay's designated market maker unit the largest DMM at the NYSE.

  • Specialist firm LaBranche halted for News Pending. Rumors that the firm has been for sale has been around for months now....

  • doctor

    It appears that Washington is about to enact sweeping legislation that will be the greatest shift in public policy in decades. Yes, we can bemoan the lack of a completely private enterprise driven system but the reality is Big Brother is here and he's not going away. Without a doubt there will be implications for investors that need to be considered; and it's not all bad news from an investment perspective.

  • Warren Buffett agreed to buy one of America’s largest railroad companies in a deal valued at $44 billion. So what does Buffett’s move say about investing in America right now? David Pearl, co-CIO of Epoch Investment Partners, shared his insights.

  • Considering investors stepped into this market and bid shares higher even with unemployment at a 26-year high, is it safe to assume the bulls are back?

  • Pharma Stocks

    Critics have been saying for years that big pharma's been pi..., er, throwing away money on relatively unproductive research and development of new drugs. But a new study shows urine could eventually provide a new revenue stream.

  • Companies that provide laboratory services are down late in the day on talk that the the new Senate Finance Committee bill on healthcare will contain a co-pay for labs that will save some $20 billion over 10 years, which may put pressure on profits of those companies.